Advancing targeted protein degradation for metabolic diseases therapy
Authors:
Open Access
- 21 December 2022
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 188, 106627
Abstract
No abstract availableKeywords
This publication has 208 references indexed in Scilit:
- Structure of an E3:E2∼Ub Complex Reveals an Allosteric Mechanism Shared among RING/U-box LigasesMolecular Cell, 2012
- Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysisNature, 2012
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomideLeukemia, 2012
- Inhibitory effect of dietary lipids on chaperone-mediated autophagyProceedings of the National Academy of Sciences, 2012
- The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradationNature Reviews Molecular Cell Biology, 2011
- ERR receptors as potential targets in osteoporosisTrends in Endocrinology & Metabolism, 2010
- Protein Knockdown Using Methyl Bestatin−Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding ProteinsJournal of the American Chemical Society, 2010
- Abdominal obesity and metabolic syndromeNature, 2006
- Antigenicity and Immunogenicity of Synthetic PeptidesBiologicals, 2001
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991